A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors

ICIC, San José

Charlotte Maxeke Johannesburg Hospital; Haemophilia Comprehensive Care Center, Johannesburg

North Shore/Long Island Jewish PRIME; Pediatric Hematology/Oncology & Stem Cell Transplantation, New Hyde Park

"IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi Angelo Bianchi e Bonomi", Milan

Hospital Universitario la Paz; Servicio de Hematologia, Madrid

Children'S Healthcare of Atlanta, Atlanta

Istanbul Uni Istanbul Medical Faculty, Istanbul

Istanbul University, Cerrahpasa Medical Faculty; Pediatrics Department, Istanbul

Ege University, School of Medicine; Pediatrics Department, Izmir

Hospital Universitario Virgen del Rocio; Servicio de Hematologia, Seville

Hospital Universitario la Fe; Servicio de Hematologia, Valencia

Children's Hospital of Michigan; Pediatrics, Detroit

Universitätsklinikum Bonn; Institut für Experimentelle Hämatologie und Transfusionsmedizin, Bonn

Rush Medical Center, Chicago

Hopital Cardio-vasculaire Louis Pradel; Hemostase clinique, Bron

Groupe Hospitalier Necker Enfants Malades, Paris

University of Colorado Denver, Children's Hospital, Aurora

Children's Hospital Los Angeles, Los Angeles

CH de Bicetre; Centre de Traitement d' Hemophilie, Le Kremlin-Bicêtre

Oregon Health & Science Uni ; Dept of Pediatrics, Portland

Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia, Seattle

Nagoya University Hospital, Aichi

Hospital of the University of Occupational and Environmental Health,Japan, Kitakyushu-shi

Nara Medical University Hospital, Nara

Shizuoka Children's Hospital, Shizuoka

Ogikubo Hospital, Tokyo

Adana Acibadem Hospital; Pediatric Hematology, Adana

Great Ormond street Hospital for Children NHS Foundation Trust; Haemophilia Centre, London